0001127602-16-046112.txt : 20160311 0001127602-16-046112.hdr.sgml : 20160311 20160311165255 ACCESSION NUMBER: 0001127602-16-046112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160309 FILED AS OF DATE: 20160311 DATE AS OF CHANGE: 20160311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 TECHNOLOGY PARK STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVANGIE DANIEL J CENTRAL INDEX KEY: 0001187406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 161501347 MAIL ADDRESS: STREET 1: 85 SWANSON ROAD CITY: BOXBOROUGH STATE: MA ZIP: 01719 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-03-09 0001145197 INSULET CORP PODD 0001187406 LEVANGIE DANIEL J C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821 1 President, Drug Delivery Common Stock 2016-03-09 4 M 0 15545 15.14 A 25358 D Common Stock 2016-03-09 4 S 0 7600 31.04 D 17758 D Common Stock 2016-03-10 4 M 0 9455 15.14 A 27213 D Common Stock 2016-03-10 4 S 0 4699 30.65 D 22514 D Stock Option (Right to Buy) 15.14 2016-03-09 4 M 0 15545 0 D 2021-11-01 Common Stock 15545 9455 D Stock Option (Right to Buy) 15.14 2016-03-10 4 M 0 9455 0 D 2021-11-01 Common Stock 9455 0 D Includes 1,000 restricted stock units granted on June 3, 2013, which vest on April 30, 2016; 2,000 restricted stock units granted on June 2, 2014, which vest one-half of the total units on April 30, 2016 and one-half of the total units on April 30, 2017; and 6,813 performance share units granted on April 1, 2015, which vest one-third of the total performance share units on April 1, 2016, one-third of the total performance share units on April 1, 2017 and one-third of the performance share units on April 1, 2018, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $31.00 to $31.46. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $30.12 to $31.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant. /s/ David Colleran, attorney-in-fact 2016-03-11